Autres langues LabGenomics Co., Ltd.

Actions

A084650

KR7084650001

Installations et services en soins de santé

Cours en clôture Korea S.E. 02/10/2026			Varia. 5j.	Varia. 1 janv.
2 655,00 ^KRW	-4,15%		-9,23%	-70,68%

15/06	Daewoong Bio et LabGenomics collaborent pour introduire en Corée une technologie de diagnostic de la maladie d'Alzheimer par prise de sang	CI
23/06/25	LabGenomics nomme Ryu Jae-hak au poste de PDG	MT

Autres langues

24/08	LabGenomics Co., Ltd.(KOSDAQ:A084650) dropped from S&P Global BMI Index
15/06	Daewoong Bio and LabGenomics Collaborate to Introduce Blood-Based Alzheimer?s Disease Diagnostic Technology in Korea
20/05	LabGenomics Co., Ltd. announced that it has received KRW 20 billion in funding
12/05	LabGenomics Co., Ltd. announced that it expects to receive KRW 20 billion in funding
23/06/25	LabGenomics Appoints CEO
24/07/23	LabGenomics USA LLC announced that it has received KRW 75.948 billion in funding from LabGenomics Co., Ltd.
03/07/23	LabGenomics USA LLC announced that it expects to receive KRW 70 billion in funding from LabGenomics Co., Ltd.
11/04/23	Abion Inc. announced that it expects to receive KRW 21 billion in funding from LabGenomics Co., Ltd., Atinum Investment Co., Ltd, NH Investment & Securities Co., Ltd., Investment and others
10/04/23	N Citron, Inc. announced that it has received KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.
31/03/23	N Citron, Inc. announced that it expects to receive KRW 1.999999776 billion in funding from LabGenomics Co., Ltd.
18/01/23	LabGenomics Co., Ltd. announced that it has received KRW 22.71198072 billion in funding
20/08/22	LabGenomics Co., Ltd. announced that it expects to receive KRW 34.09367874 billion in funding
19/08/22	LabGenomics Co., Ltd. announced that it expects to receive KRW 82.71198072 billion in funding from Luha Private Equity and another investor
28/08/21	LabGenomics Co., Ltd.'s Equity Buyback announced on May 28, 2021, has expired.
04/08/21	Tranche Update on LabGenomics Co., Ltd.'s Equity Buyback Plan announced on May 28, 2021.
28/05/21	LabGenomics Co., Ltd. announces an Equity Buyback for 214,132 shares.
28/05/21	LabGenomics Co., Ltd. authorizes a Buyback Plan.
03/04/21	LabGenomics : Maryland audit faults procurement of 500K virus tests
19/11/20	Optical Biosystems, Inc. announced that it has received $20 million in funding from a group of investors
21/09/20	LabGenomics Co., Ltd.(KOSDAQ:A084650) added to S&P Global BMI Index
01/06/20	LabGenomics Co., Ltd. agreed to acquire 9.09% stake in Calth Corporation for KRW 2 billion.
20/01/20	Contextual Genomics Partners with Lab Genomics
30/08/19	LabGenomics Co., Ltd's Equity Buyback announced on July 30, 2019, has expired.
30/07/19	LabGenomics Co., Ltd. announces an Equity Buyback for 101,419 shares.
30/07/19	LabGenomics Co., Ltd. authorizes a Buyback Plan.